thyroid cancer
Veracyte Q2 Revenues More Than Double on Test Volume Spike
The company's commercial test volume and test revenues were both up more than 200 percent compared to the same quarter last year.
Bayer, Veracyte to Identify Therapy-Resistant Thyroid Cancer Patients
Bayer will offer Veracyte's Afirma Xpression Atlas to identify underlying drivers in tumors of late-stage or metastatic thyroid cancer patients resistant to radioactive iodine therapy.
Tempus Raises $200M in Series G2, Inks Oncology Testing Collaboration With Bayer
The partners are starting by testing patients with colorectal and thyroid cancers using the 648-gene Tempus xT assay, but could expand to other areas in the future.
Biocartis Collaborating With GeneproDx, Endpoint Health on Tests for Idylla Platform
The deal with GeneproDx will focus on thyroid cancer, while the agreement with Endpoint Health will focus on CDx development for critical illnesses.
NeoGenomics, Lilly Oncology Partner for Thyroid Cancer Testing Program
NeoGenomics will offer the Thyroid Profile and the NGS Thyroid Profile plus RET FISH test as part of the program, which is sponsored by Lilly.